In another report, the VAF of TP53 mutations in bone marrow was between 0.1 and 7.7% in young patients who had predisposing syndromes for leukemia, including severe congenital neutropenia and Shwachman-Diamond syndrome [169]. This evidence concerns the gene TP53 and leukemia.